The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...

New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients ...

Each receives $2,000, and will compete for another $1.2 million. See all California students, their schools, and their ...

After 50 years, scientists discover the MAL blood grouping system, solving a genetic mystery and improving transfusion safety ...

The firms will combine Caris' multimodal genomic data with Ontada's community oncology-based real-world data to support cancer drug development.

Solomon Moshkevich, Natera's president of clinical diagnostics, said that the firm has seen strong growth in MRD testing in 2023 and 2024 that has been driven by both new physician users and existing ...

Mayo Clinic today unveiled separate groundbreaking collaborations with Microsoft Research and with Cerebras Systems in the field of generative artificial intelligence (AI), designed to personalize ...

The Direct-to-Consumer Genetic Testing market is anticipated to sustain a robust Compound Annual Growth Rate (CAGR) of 9.45% ...

"Joining Epic’s Aura Network will enhance our customer experience and increase accessibility to the genetic testing services we provide," said Kengo Takishima, President and Chief Executive Officer at ...

Genetically modified males transfer toxic proteins during mating, drastically shortening female lifespans and paving the way for rapid pest control and the fight against diseases like malaria ...

The OncoExTra™ test applies comprehensive tumor profiling, utilizing whole exome and whole transcriptome sequencing, to aid in therapy selection for patients with advanced, metastatic, refractory, ...